Related Experiment Videos

Oncogenes belonging to the CSF-1 transduction pathway direct p53 tumor suppressor effects to monocytic

R Martinelli1, G Blandino, R Scardigli

  • 1Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, C.R.S., Rome, Italy.

Oncogene
|July 31, 1997
PubMed

Insights

Wild-type p53 (wt-p53) expression induces varied outcomes in tumor cells. In 32D myeloid progenitors, wt-p53 triggers monocytic differentiation, highlighting context-dependent p53 signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Wild-type p53 (wt-p53) expression can induce diverse cellular outcomes like growth arrest, apoptosis, or differentiation.
  • The cellular context significantly influences the final outcome of p53-mediated effects.
  • Previous studies showed varied wt-p53 effects in different tumor cell lines.

Purpose of the Study:

  • To investigate the impact of wt-p53 expression on 32D myeloid progenitor cells transformed with different oncogenes.
  • To determine if wt-p53 induces similar outcomes in a single cell type expressing distinct oncogenes.
  • To explore the interaction between p53 activity and cellular signaling pathways.

Main Methods:

  • Overexpression of exogenous wt-p53 in 32D myeloid progenitor cells.
  • Transformation of 32D cells with specific oncogenes (v-src or c-fms).
  • Analysis of cellular differentiation and signaling pathway activation.

Main Results:

  • 32D cells transformed with v-src or c-fms oncogenes consistently showed monocytic differentiation upon wt-p53 expression.
  • This outcome occurred despite 32D cells not typically expressing the CSF-1 receptor or undergoing monocytic differentiation spontaneously.
  • The results suggest that wt-p53's tumor-suppressive effects are modulated by activated signaling pathways within the transformed cells.

Conclusions:

  • The cellular context, specifically activated oncogenic signaling, dictates the outcome of wt-p53 expression.
  • wt-p53 can induce specific differentiation pathways (monocytic) in 32D cells when they are transformed with CSF-1 pathway oncogenes.
  • These findings underscore the critical interplay between p53 and cellular signaling in determining cancer cell fate.

Related Concept Videos